BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36106712)

  • 1. High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in
    Hussein AR; Rezk MR; Fathalla FAA; El-Saharty YS; Nadim AH
    Anal Methods; 2022 Oct; 14(38):3757-3765. PubMed ID: 36106712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular size distribution assessment of Haemophilus influenzae vaccine containing lactose by HPAEC-PAD and colorimetric assays.
    Nadim AH; Hussein AR; Rezk MR; Fathalla FAA; El-Saharty YS
    Anal Biochem; 2022 Sep; 653():114790. PubMed ID: 35724942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study on saccharide quantification of the
    Rosskopf U; Daas A; Terao E; von Hunolstein C
    Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
    van der Put RM; de Haan A; van den IJssel JG; Hamidi A; Beurret M
    Vaccine; 2015 Nov; 33(48):6908-13. PubMed ID: 25045809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HCl.
    Lei QP; Lamb DH; Heller R; Pietrobon P
    J Pharm Biomed Anal; 2000 Jan; 21(6):1087-91. PubMed ID: 10708393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.
    Guo YY; Anderson R; McIver J; Gupta RK; Siber GR
    Biologicals; 1998 Mar; 26(1):33-8. PubMed ID: 9637747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection.
    Tsai CM; Gu XX; Byrd RA
    Vaccine; 1994 Jun; 12(8):700-6. PubMed ID: 8091847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
    Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
    Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
    Sturgess AW; Rush K; Charbonneau RJ; Lee JI; West DJ; Sitrin RD; Hennessy JP
    Vaccine; 1999 Mar; 17(9-10):1169-78. PubMed ID: 10195629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of phosphorus in Haemophilus influenzae type b conjugate vaccines by inductively coupled plasma-atomic emission spectrometry.
    Swartz LA; Progar JJ; May JC
    Biologicals; 2000 Dec; 28(4):227-31. PubMed ID: 11237358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations.
    Saydam M; Rigsby P; Mawas F
    Biologicals; 2014 Jan; 42(1):29-33. PubMed ID: 24200313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
    de Haan A; van der Put RM; Beurret M
    Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths.
    Rana R; Dalal J; Singh D; Kumar N; Hanif S; Joshi N; Chhikara MK
    Vaccine; 2015 May; 33(23):2646-54. PubMed ID: 25907408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of saccharide in Haemophilus influenzae type b glycoconjugate vaccines, alone and in combination with DPT, by use of high-performance anion-exchange chromatography with pulsed amperometric detection.
    Bardotti AA; Ravenscroft NN; Ricci SS; D'Ascenzi SS; Guarnieri VV; Averani GG; Constantino PP
    Vaccine; 2000 Apr; 18(19):1982-93. PubMed ID: 10706959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.
    Ravi G; Venkatesh YP
    Glycoconj J; 2014 Nov; 31(8):573-85. PubMed ID: 25108762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
    Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
    Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
    Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
    Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.